An open, randomized, parallel-group trial of the efficacy and safety of the RB-2410113 medicinal product versus a reference product in patients with seasonal allergic rhinitis - Mometasone Furoate
An open, randomized, parallel-group trial of the efficacy and safety of RB-2410114 medicinal product versus a reference product in patients with seasonal allergic rhinitis
An International, Open, Randomized, Comparative study of the efficacy and safety of the medicinal products Glycopyrronium bromide plus Indacaterol 50 plus 110 μg inhalation powder capsules (PSK Pharma LLC, Russia) and Ultibro Breezhaler 50 plus 110μg inhalation powder capsules(Novartis Pharma AG, Switzerland) in subjects with COPD
100 项与 PSK Pharma LLC 相关的临床结果
0 项与 PSK Pharma LLC 相关的专利(医药)
100 项与 PSK Pharma LLC 相关的药物交易
100 项与 PSK Pharma LLC 相关的转化医学